MedPath

Innolife Co., Ltd.

Innolife Co., Ltd. logo
πŸ‡¨πŸ‡³China
Ownership
Private, Subsidiary
Established
2014-08-18
Employees
-
Market Cap
-
Website
http://www.innolife.com.cn

Study to Evaluate Effects of INL1 in Patients With Heart Failure and Reduced Ejection Fraction

Phase 2
Conditions
Reduced Ejection Fraction
Heart Failure
Interventions
Other: Placebo
First Posted Date
2019-03-14
Last Posted Date
2022-03-31
Lead Sponsor
Innolife Co., Ltd.
Target Recruit Count
200
Registration Number
NCT03875183
Locations
πŸ‡ΊπŸ‡Έ

Stern Cardiovascular, Germantown, Tennessee, United States

πŸ‡ΊπŸ‡Έ

UCLA School of Medicine, Torrance, California, United States

πŸ‡ΊπŸ‡Έ

Innovative Research of West Florida, Inc., Clearwater, Florida, United States

and more 10 locations
Β© Copyright 2025. All Rights Reserved by MedPath